Andelyn Curator Biomanufacturing Platform Supports Fayuvi Gene Therapy Approval

Monday, September 21, 2026John SterlingView original

Sanfilippo syndrome type A (MPS IIIA) is a rare, fatal lysosomal storage disease that primarily affects the central nervous system and is marked by rapid neurodegeneration beginning in early childhood.

The post Andelyn Curator Biomanufacturing Platform Supports Fayuvi Gene Therapy Approval appeared first on GEN - Genetic Engineering and Biotechnology News.